Increased risk of dementia in patients with osteoporosis: A population-based retrospective cohort analysis

Age

Volumn 36, Issue 2, 2014, Pages 967-975

  Chang, Kuang Hsi ^a,b   Chung, Chi Jung ^b   Lin, Cheng Li ^c   Sung, Fung Chang ^b   Wu, Trong Neng ^b   Kao, Chia Hung ^c,d  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Alzheimer's disease; Dementia; National Health Insurance Research Database (NHIRD); Osteoporosis

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; ESTROGEN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DEMENTIA; DISEASE ASSOCIATION; ESTROGEN THERAPY; FEMALE; HIGH RISK PATIENT; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; OSTEOPOROSIS; POPULATION RESEARCH; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; TAIWAN;

AGED; AGED, 80 AND OVER; DEMENTIA; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; OSTEOPOROSIS; POPULATION SURVEILLANCE; RETROSPECTIVE STUDIES; RISK FACTORS; TAIWAN;

EID: 84898878216     PISSN: 01619152     EISSN: 15744647     Source Type: Journal    
DOI: 10.1007/s11357-013-9608-x     Document Type: Article

References (41)

1. Alzheimer's Association (2012) 2012 Alzheimer's disease facts and figures. Alzheimers Dement 8:131-168
2. Annual Report of Tobacco, Alcohol Consumption Investigation in Taiwan Area. Taipei, Taiwan: Bureau of Tobacco and Alcohol Monopoly, Taiwan Provincial Government, 1993
3. Anstey KJ, Mack HA, Cherbuin N (2009) Alcohol consumption as a risk factor for dementia and cognitive decline: meta-analysis of prospective studies. Am J Geriatr Psychiatry 17:542-555
4. Buchner DM, Larson EB (1987) Falls and fractures in patients with Alzheimer-type dementia. JAMA 257:1492-1495
5. Cataldo JK, Prochaska JJ, Glantz SA (2011) Cigarette smoking is a risk factor for Alzheimer's disease: an analysis controlling for tobacco industry affiliation. J Alzheimers Dis 24:101-108
6. Chang KP, Center JR, Nguyen TV, Eisman JA (2004) Incidence of hip and other osteoporotic fractures in elderly men and women: Dubbo Osteoporosis Epidemiology Study. J Bone Miner Res 19:532-536
7. Cheng TM (2009) Taiwan's National Health Insurance system: high value for the dollar. In: Okma KGH, Crivelli L (eds) Six countries, six reform models: the health reform experience of Israel, the Netherlands, New Zealand, Singapore, Switzerland and Taiwan. World Scientific, New Jersey, pp 71-204
8. Cummings SR, Nevitt MC, Browner WS, Stone K, Fox KM, Ensrud KE, Cauley J, Black D, Vogt TM (1995) Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. N Engl J Med 332:767-773
9. Deng J, Zhou DH, Li J, Wang YJ, Gao C, Chen M (2006) A 2-year follow-up study of alcohol consumption and risk of dementia. Clin Neurol Neurosurg 108:378-383
10. Deng J, Shen C, Wang YJ, Zhang M, Li J, Xu ZQ, Gao CY, Fang CQ, Zhou HD (2010) Nicotine exacerbates tau phosphorylation and cognitive impairment induced by amyloid-beta 25-35 in rats. Eur J Pharmacol 637:83-88
11. Ferri CP, Prince M, Brayne C, Brodaty H, Fratiglioni L, Ganguli M, Hall K, Hasegawa K, Hendrie H, Huang Y, Jorm A, Mathers C, Menezes PR, Rimmer E, Scazufca M, Alzheimer's Disease International (2005) Global prevalence of dementia: a Delphi consensus study. Lancet 366:2112-2117
12. Fratiglioni L, Grut M, Forsell Y, Viitanen M, Grafström M, Holmén K, Ericsson K, Bäckman L, Ahlbom A, Winblad B (1991) Prevalence of Alzheimer's disease and other dementias in an elderly urban population: relationship with age, sex, and education. Neurology 41:1886-1892
13. Fujiwara S, Kasagi F, Yamada M, Kodama K (1997) Risk factors for hip fracture in a Japanese cohort. J Bone Miner Res 12:998-1004
14. Giangregorio LM, Jantzi M, Papaioannou A, Hirdes J, Maxwell CJ, Poss JW (2009) Osteoporosis management among residents living in long-term care. Osteoporos Int 20:1471-1478
15. Haasum Y, Fastbom J, Fratiglioni L, Johnell K (2012) Undertreatment of osteoporosis in persons with dementia? A population-based study. Osteoporos Int 23:1061-1068
16. Häussler B, Gothe H, Göl D, Glaeske G, Pientka L, Felsenberg D (2007) Epidemiology, treatment and costs of osteoporosis in Germany - the BoneEVA Study. Osteoporos Int 18:77-84
17. Henderson VW (2009) Aging, estrogens, and episodic memory in women. Cogn Behav Neurol 22:205-214
18. Hughes DE, Wright KR, Uy HL, Sasaki A, Yoneda T, Roodman GD, Mundy GR, Boyce BF (1995) Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo. J Bone Miner Res 10:1478-1487
19. Jilka RL, Hangoc G, Girasole G, Passeri G, Williams DC, Abrams JS, Boyce B, Broxmeyer H, Manolagas SC (1992) Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science 257:88-91
20. Juan D, Zhou DH, Li J, Wang JY, Gao C, Chen M (2004) A 2-year follow-up study of cigarette smoking and risk of dementia. Eur J Neurol 11:277-282
21. Kanis JA, Oden A, Johnell O, Jonsson B, de Laet C, Dawson A (2001) The burden of osteoporotic fractures: a method for setting intervention thresholds. Osteoporos Int 12:417-427
22. Kanis JA, McCloskey EV, Johansson H, Cooper C, Rizzoli R, Reginster JY, Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the Committee of Scientific Advisors of the International Osteoporosis Foundation (IOF) (2008) European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 19:399-428
23. Loskutova N, Honea RA, Vidoni ED, Brooks WM, Burns JM (2009) Bone density and brain atrophy in early Alzheimer's disease. J Alzheimers Dis 18:777-785
24. Lu JF, Hsiao WC (2003) Does universal health insurance make health care unaffordable? Lessons from Taiwan. Health Aff 22:77-88
25. Masud T, Morris RO (2001) Epidemiology of falls. Age Ageing 30(Suppl 4):3-7
26. Oddo S, Caccamo A, Green KN, Liang K, Tran L, Chen Y, Leslie FM, LaFerla FM (2005) Chronic nicotine administration exacerbates tau pathology in a transgenic model of Alzheimer's disease. Proc Natl Acad Sci U S A 102:3046-3051
27. Orimo H, Nakamura T, Hosoi T, Iki M, Uenishi K, Endo N, Ohta H, Shiraki M, Sugimoto T, Suzuki T, Soen S, Nishizawa Y, Hagino H, Fukunaga M, Fujiwara S (2012) Japanese 2011 guidelines for prevention and treatment of osteoporosis - executive summary. Arch Osteoporos 7:3-20
28. Patterson C, Feightner JW, Garcia A, Hsiung GY, MacKnight C, Sadovnick AD (2008) Diagnosis and treatment of dementia: 1. Risk assessment and primary prevention of Alzheimer disease. CMAJ 178:548-556
29. Peters R, Peters J, Warner J, Beckett N, Bulpitt C (2008) Alcohol, dementia and cognitive decline in the elderly: a systematic review. Age Ageing 37:505-512
30. Schneider LS, Finch C (1997) Can estrogen prevent neurodegeneration? Drugs Aging 11:87-95
31. Tan ZS, Seshadri S, Beiser A, Zhang Y, Felson D, Hannan MT, Au R, Wolf PA, Kiel DP (2005) Bone mineral density and the risk of Alzheimer disease. Arch Neurol 62:107-111
32. Turgeon JL, McDonnell DP, Martin KA, Wise PM (2004) Hormone therapy: physiological complexity belies therapeutic simplicity. Science 304:1269-1273
33. Tysiewicz-Dudek M, Pietraszkiewicz F, Drozdzowska B (2008) Alzheimer's disease and osteoporosis: common risk factors or one condition predisposing to the other? Ortop Traumatol Rehabil 10:315-323
34. Weller II (2000) The relation between hip fracture and Alzheimer's disease in the Canadian national population health survey health institutions data, 1994-1995. A cross-sectional study. Ann Epidemiol 10:461
35. Weller I, Schatzker J (2004) Hip fractures and Alzheimer's disease in elderly institutionalized Canadians. Ann Epidemiol 14:319-324
36. Wright RM (2007) Use of osteoporosis medications in older nursing facility residents. J Am Med Dir Assoc 8:453-457
37. Yaffe K, Sawaya G, Lieberburg I, Grady D (1998) Estrogen therapy in postmenopausal women: effects on cognitive function and dementia. JAMA 279:688-695
38. Yaffe K, Browner W, Cauley J, Launer L, Harris T (1999) Association between bone mineral density and cognitive decline in older women. J Am Geriatr Soc 47:1176-1182
39. Yaffe K, Tocco M, Petersen RC, Sigler C, Burns LC, Cornelius C, Khachaturian AS, Irizarry MC, Carrillo MC (2012) The epidemiology of Alzheimer's disease: laying the foundation for drug design, conduct, and analysis of clinical trials. Alzheimers Dement 8:237-242
40. Zandi PP, Carlson MC, Plassman BL, Welsh-Bohmer KA, Mayer LS, Steffens DC, Breitner JC, Cache County Memory Study Investigators (2002) Hormone replacement therapy and the incidence of Alzheimer disease in older women: the Cache County Study. JAMA 288:2123-2129
41. Zhou R, Deng J, Zhang M, Zhou HD, Wang YJ (2011) Association between bone mineral density and the risk of Alzheimer's disease. J Alzheimers Dis 24:101-108